Reply to: Direct to Patient


Ed Groleau
Participant

Reply to: Direct to Patient

Given the current situation many countries are relaxing their requirements for D2P shipments. Check with the local agency to find out their current policy. The FDA has issued a guidance.

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-guidance-conducting-clinical-trials?utm_campaign=031820_PR_Coronavirus%20Update%3A%20FDA%20Issues%20Clinical%20Trial%20Guidance&utm_medium=email&utm_source=Eloqua